THE UNSPOKEN MEDICINE PODCAST LLC – Trademark Portfolio
Entity Type: 16
THE UNSPOKEN MEDICINE PODCAST LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 2 filings in this category. The portfolio also extends into Class 25 (Clothing) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include THE UNSPOKEN MEDICINE. The owner is based in Pittsfield, MA.
82 Wendell Ave. STE 100
Pittsfield, MA 01201
Showing of trademarks Trademarks
Trademark Classifications
THE UNSPOKEN MEDICINE PODCAST LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does THE UNSPOKEN MEDICINE PODCAST LLC have?
THE UNSPOKEN MEDICINE PODCAST LLC has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does THE UNSPOKEN MEDICINE PODCAST LLC file in?
THE UNSPOKEN MEDICINE PODCAST LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 25 (Clothing), Class 16 (Paper Goods). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are THE UNSPOKEN MEDICINE PODCAST LLC's most well-known trademarks?
THE UNSPOKEN MEDICINE PODCAST LLC's registered trademark portfolio includes well-known marks such as THE UNSPOKEN MEDICINE. These are among 1 currently registered trademark in the portfolio.
What is THE UNSPOKEN MEDICINE PODCAST LLC's trademark registration success rate?
THE UNSPOKEN MEDICINE PODCAST LLC has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.